Literature DB >> 22086365

Immunoadsorption therapy for steroid-unresponsive relapses in patients with multiple sclerosis.

Corinna Trebst1, Paul Bronzlik, Jan T Kielstein, Bernhard M W Schmidt, Martin Stangel.   

Abstract

BACKGROUND: Therapeutic plasma exchange (TPE) in steroid-unresponsive relapses of patients with multiple sclerosis (MS) is an established therapy with response rates of up to 70%. Immunoadsorption (IA) specifically removes immunoglobulins from the patient's plasma. It is hypothesized that IA therapy might be better tolerated than and as effective as TPE in the treatment of MS relapses. Experiences with IA therapy of steroid-unresponsive MS relapses are limited.
METHODS: We report our experiences with IA therapy in a series of 10 patients with steroid-unresponsive MS relapses.
RESULTS: A marked to moderate clinical response with clear gain of function was observed in 66% of our patients. IA therapy was well tolerated.
CONCLUSIONS: IA therapy is an effective and well-tolerated therapeutic option for steroid-unresponsive MS relapses.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22086365     DOI: 10.1159/000332397

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  12 in total

1.  [Tryptophan immunoadsorption for multiple sclerosis and neuromyelitis optica: therapy option for acute relapses during pregnancy and breastfeeding].

Authors:  F Hoffmann; A Kraft; F Heigl; E Mauch; J Koehler; L Harms; T Kümpfel; W Köhler; R Klingel; C Fassbender; S Schimrigk
Journal:  Nervenarzt       Date:  2015-02       Impact factor: 1.214

2.  [Therapeutic apheresis for autoimmune encephalitis: a nationwide data collection].

Authors:  S Ehrlich; C M Fassbender; C Blaes; C Finke; A Günther; L Harms; F Hoffmann; K Jahner; R Klingel; A Kraft; T Lempert; M Tesch; J Thomsen; H Topka; J Jochim; C Veauthier; W Köhler
Journal:  Nervenarzt       Date:  2013-04       Impact factor: 1.214

3.  Immunoadsorption or plasma exchange in the treatment of autoimmune encephalitis: a pilot study.

Authors:  Josephine Heine; Lam-Thanh Ly; Ina Lieker; Torsten Slowinski; Carsten Finke; Harald Prüss; Lutz Harms
Journal:  J Neurol       Date:  2016-09-07       Impact factor: 4.849

Review 4.  Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders.

Authors:  Ingo Kleiter; Ralf Gold
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

5.  Immunoadsorption therapy in patients with multiple sclerosis with steroid-refractory optical neuritis.

Authors:  Michael J Koziolek; Desiree Tampe; Matthias Bähr; Hassan Dihazi; Klaus Jung; Dirk Fitzner; Reinhard Klingel; Gerhard A Müller; Bernd Kitze
Journal:  J Neuroinflammation       Date:  2012-04-26       Impact factor: 8.322

6.  Outcome of MS relapses in the era of disease-modifying therapy.

Authors:  Muriel Stoppe; Maria Busch; Luise Krizek; Florian Then Bergh
Journal:  BMC Neurol       Date:  2017-08-07       Impact factor: 2.474

Review 7.  Therapeutic Apheresis in Acute Relapsing Multiple Sclerosis: Current Evidence and Unmet Needs-A Systematic Review.

Authors:  Leoni Rolfes; Steffen Pfeuffer; Tobias Ruck; Nico Melzer; Marc Pawlitzki; Michael Heming; Marcus Brand; Heinz Wiendl; Sven G Meuth
Journal:  J Clin Med       Date:  2019-10-04       Impact factor: 4.241

8.  Dramatic recovery of steroid-refractory relapsed multiple sclerosis following Fingolimod discontinuation using selective immune adsorption.

Authors:  Roberto De Masi; Salvatore Accoto; Stefania Orlando; Vincenzo De Blasi; Sergio Pasca; Rocco Scarpello; Leo Spagnolo; Adele Idolo; Antonella De Donno
Journal:  BMC Neurol       Date:  2015-07-31       Impact factor: 2.474

9.  Tryptophan immunoadsorption during pregnancy and breastfeeding in patients with acute relapse of multiple sclerosis and neuromyelitis optica.

Authors:  Frank Hoffmann; Andrea Kraft; Franz Heigl; Erich Mauch; Jürgen Koehler; Lutz Harms; Tania Kümpfel; Wolfgang Köhler; Sven Ehrlich; Antonios Bayas; Julia Weinmann-Menke; Carolin Beuker; Karl-Heinz Henn; Ilya Ayzenberg; Gisa Ellrichmann; Kerstin Hellwig; Reinhard Klingel; Cordula Marie Fassbender; Harald Fritz; Torsten Slowinski; Horst Weihprecht; Marcus Brand; Thomas Stiegler; Jan Galle; Sebastian Schimrigk
Journal:  Ther Adv Neurol Disord       Date:  2018-05-28       Impact factor: 6.570

10.  Plasma Exchange or Immunoadsorption in Demyelinating Diseases: A Meta-Analysis.

Authors:  Mark Lipphardt; Manuel Wallbach; Michael J Koziolek
Journal:  J Clin Med       Date:  2020-05-25       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.